4//SEC Filing
Hindman Andrew A. 4
Accession 0001179110-21-010638
CIK 0001583107other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 7:53 PM ET
Size
4.8 KB
Accession
0001179110-21-010638
Insider Transaction Report
Form 4
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
- Award
Ordinary Shares
2021-12-02+340,000→ 507,258 total
Footnotes (1)
- [F1]On December 2, 2021, the reporting person was granted 340,000 RSUs. 240,000 RSUs are subject to service-based vesting conditions and the remaining 100,000 RSUs vest based on the achievement of share price appreciation targets as well as continued employment.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607965
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 7:53 PM ET
- Size
- 4.8 KB